Furthermore, increased expression of ADD3, another member of the adducin family, in TMZ-resistant GBM cells and in glioma stem-like cells has previously been reported [84], implying a potential positive association between adducin and the CSC phenotype. This evidence concerns the gene ADD3 and central nervous system cancer.